Patent · US Active

Particulate compositions for pulmonary delivery

US7384649B2 · kind B2 · utility

23Cited by
123References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 5, 2006
Grant dateJun 10, 2008
Priority date
Expiry dateDec 5, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/1694
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention concerns an improved particulate composition for delivering a drug to the pulmonary system. Applicants disclose a method of identifying an optimal form of aerodynamically light particles which are highly dispersible. The particles of the instant invention are made by creating hollow, spherical drug particles (i.e., progenitor particles) that collapse in the process of particle formation, leading to wrinkled, thin-walled drug particles of very low envelope density. Additionally, Applicants have found that such particles are especially optimal for inhaled aerosols when the surface area parameter (σ) is greater than 2, optimally greater than 3.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.